glp-1 drugs and alcohol A cheap, already available pill is being billed as the “Ozempic of alcohol” for its ability to reduce appetites for booze, the way curb food cravings GLP-1 medications get at the
Description
The ATLAS Community Health Initiative is supported by UCLA Health, the David Geffen School of Medicine and a grant from the UCLA Clinical and Translational Science Institute (UL1TR001881)

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial

Current guidelines from the European Society of Cardiology and American Diabetes Association strongly endorse GLP-1 receptor agonists with proven cardiovascular benefit for patients with established atherosclerotic cardiovascular disease

Sawami K, Tanaka A, Node K (2022) Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists

Transient transfection, as above, was used to deliver DNA encoding mouse GLP-1RLgBiT and ARRB1/2-SmBiT fusion proteins